Redeye updates its estimates after reviewing Tessin's Q1 report, which came in below expectations.
Redeye provides an update following Corline’s Q1 2025 report.
Redeye stated InfraCom's Q1 2025 report provided further evidence that the company has overcome exec...
Redeye returns with positive estimate adjustments following GomSpace’s trading update that beat our ...
Fiskars announced yesterday evening that the CEO, Nathalie Ahlström will step down with imminent eff...
Redeye retains its positive view of Transtema following a Q1 report with strong growth but a slightl...
STENOCARE A/S (STENOCARE or the “Company”) published on May 8th the Company’s Q1-report for 2025.
Encouraging results, even if it was low season We raise our EBITA estimates 2-3% on '25e-'27e Svensk...
Alzecure har på senare tid stärkt profilen för bolagets ledande projekt, ACD856, genom att visa data...
Redeye's provides its initial take on Xbrane's Q1 report which confirmed a stronger than anticipated...
Redeye provides a brief comment on Paxman’s announcement to complete the offer for Dignitana.
Redeye comments on I-Tech’s Q1 figures that beat our estimates across the board, delivering growth o...
Redeye comments on Transtema’s Q1 report, showing strong organic growth in Sweden but a relatively s...
Sales +9% and EBIT +14% vs. ABGSCe Expect cons. to raise '25e-'27e sales by ~3-4% USD/SEK movements ...
Redeye noted InfraCom's robust profitability, surpassing its EBITDA estimate by 21%.
